Literature DB >> 21782807

Dyslipidemia in subclinical hypothyroidism in an Indian population.

Raman K Marwaha1, Nikhil Tandon, M K Garg, Ratnesh Kanwar, A Sastry, A Narang, S Arora, Kuntal Bhadra.   

Abstract

OBJECTIVES: In view of inconsistent reports on the prevalence of dyslipidemia in subclinical hypothyroidism (SCH), we studied lipid abnormalities in Indian subjects with SCH. DESIGN AND METHODS: A cross sectional study of 5343 subjects divided in two groups, Group-1 (age≤18 years) and Group-2 (age>18 years) was undertaken. They were further subdivided on the basis of their thyroid functional status: Normal (Control); SCH with TSH≤10.0mIU/L (SCH-1); and SCH with TSH>10mIU/L (SCH-2).
RESULTS: Prevalence of SCH was 14.7%. The only lipid abnormality in children and adolescents was low HDL in subjects with TSH>10mIU/L compared with controls. Serum total cholesterol (TC), and LDL cholesterol (LDL) were significantly higher in adults with TSH>10mIU/L compared to controls. There were no significant changes in lipid parameters in subjects with SCH having TSH≤10.0mIU/L, compared to controls. Serum TSH was positively and FT3 and FT4 were negatively correlated with TC and LDL.
CONCLUSIONS: Atherogenic lipid abnormalities were observed in adult subjects with SCH-2 (TSH>10.0mIU/L), and not in subjects with SCH-1 who had TSH≤10.0mIU/L in Indian population.
Copyright © 2011 The Canadian Society of Clinical Chemists. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21782807     DOI: 10.1016/j.clinbiochem.2011.07.003

Source DB:  PubMed          Journal:  Clin Biochem        ISSN: 0009-9120            Impact factor:   3.281


  10 in total

Review 1.  Subclinical hypothyroidism in childhood - current knowledge and open issues.

Authors:  Mariacarolina Salerno; Donatella Capalbo; Manuela Cerbone; Filippo De Luca
Journal:  Nat Rev Endocrinol       Date:  2016-07-01       Impact factor: 43.330

2.  The effect of glycaemic control in type 2 diabetic patients with subclinical hypothyroidism.

Authors:  X Fu; H Xia; H Mao; S Zhao; Z Wang
Journal:  J Endocrinol Invest       Date:  2016-07-30       Impact factor: 4.256

3.  Evaluation of the relationship of subclinical hypothyroidism with metabolic syndrome and its components in adolescents: a population-based study.

Authors:  Min-Kyung Lee; Yoo Mee Kim; Seo-Young Sohn; Jae-Hyuk Lee; Young Jun Won; Se Hwa Kim
Journal:  Endocrine       Date:  2019-05-01       Impact factor: 3.633

4.  ATHEROGENIC INDICES IN THE ASSESSMENT OF CARDIOVASCULAR DISEASE RISK IN CHILDREN WITH OBESITY AND SUBCLINICAL HYPOTHYROIDISM.

Authors:  N Akici; Z E Onal; T Gürbüz; C Sağ; S Kilinç
Journal:  Acta Endocrinol (Buchar)       Date:  2020 Jul-Sep       Impact factor: 0.877

5.  The effect of L-thyroxine treatment on hypothyroid symptom scores and lipid profile in children with subclinical hypothyroidism.

Authors:  Gönül Çatlı; Ahmet Anık; Hale Ünver Tuhan; Ece Böber; Ayhan Abacı
Journal:  J Clin Res Pediatr Endocrinol       Date:  2014-12

6.  High atherogenic index of plasma in subclinical hypothyroidism: Implications in assessment of cardiovascular disease risk.

Authors:  Stephen R James; Lopamudra Ray; Kandasamy Ravichandran; Sunil Kumar Nanda
Journal:  Indian J Endocrinol Metab       Date:  2016 Sep-Oct

7.  Cardiovascular Risk Factors in Children and Adolescents with Subclinical Hypothyroidism.

Authors:  Yogesh Yadav; Uma Kaimal Saikia; Dipti Sarma; Manoj Hazarika
Journal:  Indian J Endocrinol Metab       Date:  2017 Nov-Dec

8.  Association of Subclinical Hypothyroidism with Dyslipidemia and Increased Carotid Intima-Media Thickness in Children.

Authors:  Edip Unal; Alper Akın; Ruken Yıldırım; Vasfiye Demir; İsmail Yildiz; Yusuf Kenan Haspolat
Journal:  J Clin Res Pediatr Endocrinol       Date:  2016-12-23

Review 9.  Hashimoto Thyroiditis and Dyslipidemia in Childhood: A Review.

Authors:  Rade Vukovic; Aleksandra Zeljkovic; Biljana Bufan; Vesna Spasojevic-Kalimanovska; Tatjana Milenkovic; Jelena Vekic
Journal:  Front Endocrinol (Lausanne)       Date:  2019-12-10       Impact factor: 5.555

10.  Plasma lipidomic analysis shows a disease progression signature in mdx mice.

Authors:  Roula Tsonaka; Alexandre Seyer; Annemieke Aartsma-Rus; Pietro Spitali
Journal:  Sci Rep       Date:  2021-06-21       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.